The company was founded in 1979 and is headquartered in Eden Prairie, Minnesota. Surmodics - SRDX Stock Forecast, Price & News 29.80 -0.63 (-2.07) (As of 12:00 AM ET) Today's Range 29.21 30.40 50-Day Range 28.84 38.92 52-Week Range 28.27 58.95 Volume 23,908 shs Average Volume 41,891 shs Market Capitalization 416.90 million P/E Ratio N/A Dividend Yield N/A Price Target 58. The backtesting process can reveal which currency pair offers the most accurate and profitable double top/double bottom patterns. On average, they expect the companys share price to reach 58.00 in the next year. This segment offers protein stabilization reagents, substrates, surface coatings, and antigens. Their SRDX share price forecasts range from 58.00 to 58.00.
The IVD segment designs, develops, and manufactures component products and technologies for diagnostic immunoassay, as well as molecular test and biomedical research applications. In Excel, you should enter the stock name, entry price, exit price, and any other information you think is relevant. The Medical Device segment engages in the provision of surface modification coating technologies to enhance access, deliverability, and predictable deployment of medical devices and drug-delivery coating technologies to provide site-specific drug-delivery from the surface of a medical device for coronary, peripheral, neuro-vascular and structural heart, and other markets, as well as design, development, and manufacturing of interventional medical devices, primarily balloons and catheters, including drug-coated balloons for peripheral arterial disease treatment and other applications. If you want to manually backtest a strategy, a good place to start is collecting your personal trade history with that strategy. the best grades) has a 23.3 backtested annual return since inception. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). Learn more about SurModics, Inc.s (SRDX) stock grades for Value, Momentum. construct a moving average Hurst crossover strategy and back test it on the past stock price series.
Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally.
0 kommentar(er)
